Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fidia Farmaceutici SPA

www.fidiapharma.com

Latest From ratiopharm Inc.

Two Roads Diverge For Mylan: Teva Or Perrigo

Teva announced a proposal to acquire Mylan for $82 per share, or roughly $40 billion, putting Mylan’s independence and a proposal to acquire OTC drug specialist Perrigo in question. Adding to the uncertainty, Perrigo rejected Mylan’s offer after market close.

BioPharmaceutical Consumer

Two Roads Diverge For Mylan: Teva Or Perrigo

Teva announced a proposal to acquire Mylan for $82 per share, or roughly $40 billion, putting Mylan’s independence and a proposal to acquire OTC drug specialist Perrigo in question. Adding to the uncertainty, Perrigo rejected Mylan’s offer after market close.

BioPharmaceutical Deals

Actavis’ Big Bet On Diversified Hybrid Model Reflects Industry Trends

Actavis’ proposal to buy Forest Labs for $25 billion in stock and cash was driven by consolidating customers and fierce competition in traditional Western markets. Different pressures, namely the tough-to-manage patent cliff, as well as leadership succession issues and investor unrest, drove Forest into the arms of a suitor.

BioPharmaceutical United States

Evidence Growing That Drug Counterfeiters Are Targeting Generics In The EU

Counterfeit omeprazole has been found for the third time in Germany, suggesting that the generics sector must raise its game to combat this phenomenon.

BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Italy
  • Parent & Subsidiaries
  • Fidia Farmaceutici SPA
  • Senior Management
  • Ennio Arengi, Pres. & CEO
    Marilena Bianco, CFO
    Giuseppe Giorgini, Mktg. Dir.
  • Contact Info
  • Fidia Farmaceutici SPA
    Phone: (39) 498 232111
    Via Ponte della Fabbrica 3/A
    Abano Terme, I-35031
    Italy
Advertisement
Advertisement
UsernamePublicRestriction

Register